Skip to main content
. 2006 Dec 21;401(Pt 2):559–567. doi: 10.1042/BJ20061081

Figure 1. Anisomycin activates MAPKs and induces ATF3 expression.

Figure 1

COS-1 cells were treated with anisomycin (50 ng/ml) for the indicated times and analysed by immunoblot with the indicated antibodies or by RT–PCR with primers specific to ATF3 or GAPDH.